Semaglutide and Pregnancy: What You Need to Know Before, During, and After

The Quick Answer — Then the Full Story

If you're pregnant, stop semaglutide. If you're planning to become pregnant, stop it at least two months before you start trying. If you just found out you're pregnant while taking it, don't panic — but do call your provider right away.

Those are the guidelines from both the FDA and the American Diabetes Association. The reasoning behind them, and what the actual risk looks like based on current data, is more nuanced than a single sentence can capture. This guide walks through everything: the animal studies, the limited but growing human data, the "Ozempic baby" fertility phenomenon, breastfeeding considerations, and exactly how to plan your timeline if you want to have a baby while using or recently using semaglutide.

This topic carries a lot of anxiety. The information here is educational, not a substitute for talking with your OB-GYN or prescribing provider. But understanding what the data actually says — versus what fear-driven headlines suggest — can help you make informed decisions and ask better questions.

What the FDA Label Says

Semaglutide (Ozempic, Wegovy, and the new oral Wegovy pill) should be discontinued at least two months before a planned pregnancy. The FDA updated the prescribing information to advise switching from oral contraceptives to a non-oral method (or add a barrier method) for four weeks after starting semaglutide and four weeks after each dose increase, because delayed gastric emptying may reduce the effectiveness of birth control pills.

The labeling states that "based on animal reproduction studies, there may be potential risks to the fetus from exposure to semaglutide during pregnancy." The drug should be used during pregnancy "only if the potential benefit justifies the potential risk to the fetus."

In practice, this means no provider should be prescribing semaglutide to someone who is actively pregnant or planning to conceive soon. The two-month washout guidance exists because semaglutide has a long half-life — it takes about five to six weeks for the drug to be substantially cleared from your system after the last injection.

The Animal Study Data: What Actually Happened

This is the part that sounds scariest on paper, so let's walk through it carefully.

In rat studies, semaglutide caused embryo-fetal toxicity at subclinical doses. Pregnant rats given semaglutide showed increased fetal death and structural abnormalities, including problems with heart blood vessels, changes in cranial bones, vertebrae, and ribs, and reduced fetal growth. These findings coincided with reduced maternal food intake and weight loss — which itself causes developmental problems in rodent pregnancies.

In rabbit studies, semaglutide caused early pregnancy losses, structural abnormalities, and reduced fetal weight at doses equivalent to human clinical exposure.

Those are real findings. They're also findings that require context.

Mechanistic studies in rats concluded that the embryo-fetal toxicity was caused by GLP-1 receptor effects on the "inverted yolk sac placenta" — a structure that functions as a placenta in rats during early development. Here's the key part: in primates (including humans), the yolk sac does not invert to form a placenta. GLP-1 receptors are not expressed in the yolk sac membranes of primates. The specific mechanism that causes harm in rats is considered unlikely to be relevant to human pregnancies.

That doesn't mean semaglutide is safe in human pregnancy. It means the animal data, while alarming at first glance, involves a biological pathway that humans don't share. The FDA still errs on the side of caution — appropriately — because "unlikely to be relevant" is not the same as "proven safe."

Human Pregnancy Data: What We Know So Far

Human data is limited but growing. Several studies published in 2025 provide the best picture we have.

A systematic review examining five studies with a combined 1,128 semaglutide-exposed pregnancies found no clear association between semaglutide exposure and birth defects. The review noted limitations in study variability and bias risk, but the overall signal was reassuring.

A smaller study of 32 pregnancies exposed to semaglutide (plus insulin) found comparable rates of malformations, preterm birth, large-for-gestational-age infants, neonatal hypoglycemia, and jaundice when compared to pregnancies exposed solely to insulin. No consistent pattern of specific malformations emerged.

A multicenter observational study across six Teratology Information Services in Europe looked at GLP-1 receptor agonist exposure in early pregnancy and also did not find a clear increase in major congenital malformations.

These numbers are encouraging, but they come with a major caveat: the sample sizes are still too small for definitive conclusions. Detecting a rare birth defect pattern requires data from thousands of exposed pregnancies, and we're not there yet. Larger prospective registries are ongoing.

The bottom line from current human evidence: accidental first-trimester exposure does not appear to be the catastrophe that the animal data might suggest. But the data is not strong enough to say semaglutide is safe during pregnancy, which is why the guidance to stop before conceiving remains firmly in place.

The "Ozempic Baby" Phenomenon

If you've spent any time on social media searching for semaglutide and fertility, you've seen the #OzempicBaby posts. Women who struggled with infertility for years are getting pregnant — sometimes unexpectedly — after starting GLP-1 medications. The stories are striking and they're not anecdotal flukes. There's real biology behind them.

Weight loss restores ovulation. For women with obesity, losing just 5-10% of body weight can dramatically improve ovulation rates and menstrual regularity. Excess body fat produces estrogen, and elevated estrogen disrupts the hormonal signals that trigger ovulation. When that fat decreases, the hormonal balance shifts back toward fertility. Semaglutide's average weight loss of 15% is more than enough to trigger this change.

PCOS responds strongly. Polycystic ovary syndrome — one of the most common causes of infertility — is tightly linked to insulin resistance, elevated androgens, and irregular ovulation. Semaglutide improves insulin sensitivity, which helps reduce androgen levels and restore more normal LH patterns. For some women with PCOS, this means ovulating regularly for the first time in years.

GLP-1 receptors exist in the reproductive system. GLP-1 receptors are found in the ovaries and uterus. Emerging research (a 2025 review in PMC) suggests semaglutide may directly affect follicular development and ovarian function, though the clinical significance of this is still being studied.

Birth control may become less reliable. This part catches people off guard. Semaglutide slows gastric emptying, which can reduce the absorption of oral contraceptives. The FDA updated the labeling in 2023 to address this: women starting semaglutide or increasing their dose should use a backup barrier method for four weeks, or switch to a non-oral contraceptive entirely (IUD, implant, patch, ring, or injection).

The combination of restored fertility and potentially reduced oral contraceptive effectiveness explains many of the surprise pregnancies. If you're on semaglutide and don't want to become pregnant, talk to your provider about your contraceptive method. If you do want to become pregnant, the fertility boost from weight loss is genuinely good news — but you need a plan for when to stop the medication.

What to Do If You Get Pregnant While on Semaglutide

First: don't panic. The human data available so far does not show a clear pattern of harm from early pregnancy exposure. Many women have discovered they were pregnant weeks into semaglutide treatment, and the outcomes reported in the literature have been largely reassuring.

Here's what to do:

1. Stop taking semaglutide. Don't take your next dose. Because of the drug's long half-life, the semaglutide already in your system will take several weeks to clear — you can't speed that up, and you don't need to.

2. Call your prescribing provider and your OB-GYN. Let both know. They may want to schedule an early ultrasound to confirm dating and check development. Neither provider is likely to tell you the pregnancy is in danger based on semaglutide exposure alone.

3. Don't search yourself into a spiral. The animal data sounds frightening if you read it without context. The rat-specific mechanism (inverted yolk sac placenta) is not present in humans. Human data, while limited, has not shown a consistent pattern of birth defects. Your providers can give you a risk assessment based on your specific exposure timing and duration.

4. Report the exposure. Your provider may report your case to Novo Nordisk's pregnancy registry or to a teratology information service. These registries are how we build the larger datasets needed to understand outcomes more clearly.

If you were taking the oral Wegovy pill rather than the injection, the same guidance applies. Stop taking it and contact your providers.

Timeline for Stopping Before Trying to Conceive

If pregnancy is on your radar — even as a "maybe in the next year" — here's how to think about timing.

The minimum: Stop semaglutide at least two months (eight weeks) before actively trying to conceive. This allows adequate time for the drug to clear your system. Semaglutide's elimination half-life is approximately one week, meaning it takes about five to six weeks for levels to become negligible after your last dose.

The practical approach: Many providers suggest stopping about two to three months before you want to start trying. This builds in a buffer for irregular cycles to normalize (some women experience a temporary return of increased appetite and possible cycle irregularity when stopping) and ensures the drug is fully cleared.

What to expect when you stop: Appetite will increase. This is not a surprise — semaglutide was suppressing it, and removing the drug removes that suppression. You may experience some weight regain. The what happens when you stop Ozempic guide covers this in detail. Planning your nutrition and exercise strategy before stopping can help minimize regain during the preconception period.

Blood sugar monitoring: If you were using semaglutide for type 2 diabetes, your provider will need to transition you to a pregnancy-safe diabetes medication (metformin is commonly used during pregnancy, and insulin is the gold standard for gestational blood sugar management). This transition should happen before you conceive, not after.

Continue prenatal vitamins. Start taking folic acid (at least 400 mcg daily, or 800 mcg if your provider suggests it) well before conception — ideally at least one to three months prior. This is standard preconception care regardless of semaglutide use.

Breastfeeding and Semaglutide

The current consensus: semaglutide is not advised during breastfeeding. But the data is evolving.

A 2024 study examined eight breastfeeding women taking GLP-1 medications and found no detectable transfer of the drug into breast milk. That's a single small study, and it's not enough to change official guidance. Semaglutide is a large peptide molecule, which makes significant transfer into breast milk biologically unlikely — but "unlikely" and "proven safe" are different standards.

Most providers will not prescribe semaglutide to someone who is actively nursing, especially in the first six months when breastfeeding is the primary nutrition source. After six months — once complementary foods are introduced and breastfeeding is no longer the sole source of calories — some providers may be more open to the conversation, particularly if the mother has significant obesity-related health risks.

If you're done breastfeeding (or choose not to breastfeed), there's no waiting period. You can restart semaglutide as soon as your provider clears you, typically at the lowest dose with a fresh titration schedule. The semaglutide dosing chart outlines what that restart looks like.

If postpartum weight management is a priority and you're breastfeeding, talk to your provider about alternatives in the meantime. Diet, exercise, and in some cases metformin (which has a longer safety record during lactation) may bridge the gap.

What About Tirzepatide and Pregnancy?

The guidance for tirzepatide (Mounjaro, Zepbound) is essentially the same. Animal studies showed similar embryo-fetal toxicity. There's even less human pregnancy data for tirzepatide than for semaglutide since it came to market more recently. The washout period and contraceptive precautions are the same.

If you're choosing between semaglutide and tirzepatide and pregnancy is in your future, the pregnancy-related considerations don't differ meaningfully between the two. The decision should be based on other factors — efficacy, side effects, cost, insurance. See the full comparison for help weighing those.

A Note on Fertility Treatments and GLP-1 Medications

If you're actively undergoing fertility treatment (IVF, IUI, or ovulation induction), talk to your reproductive endocrinologist about semaglutide timing. Some fertility specialists ask patients to lose weight before starting a cycle and may be comfortable with semaglutide use during that preparatory phase — stopping it before the treatment cycle begins.

GLP-1 medications are not approved or studied as fertility treatments. The fertility improvements seen in clinical practice are a secondary effect of weight loss and metabolic improvement, not a direct reproductive indication. Your reproductive specialist and your prescribing provider should be communicating about timing if you're working with both.

Not sure where to start? Take the provider matching quiz to find a provider who can help you think through the intersection of weight management and family planning.

Semaglutide and Pregnancy FAQs

How long before getting pregnant should I stop semaglutide?

The FDA and the American Diabetes Association both suggest stopping semaglutide at least two months before trying to conceive. This allows adequate time for the drug to clear your system — semaglutide's half-life is about one week, so it takes approximately five to six weeks for levels to become negligible. Many providers build in an extra buffer and suggest stopping two to three months before actively trying. If pregnancy is a possibility in the near future, discuss your timeline with your provider sooner rather than later.

What happens if I get pregnant while taking Ozempic or Wegovy?

Stop taking the medication and contact both your prescribing provider and your OB-GYN. The human data available — including a systematic review of over 1,100 exposed pregnancies — has not shown a consistent increase in birth defects from first-trimester semaglutide exposure. The animal study findings involved a biological mechanism (the inverted yolk sac placenta) that doesn't exist in humans. While these results are reassuring, they're not definitive. Your providers can assess your specific situation, timing of exposure, and any additional risk factors.

Can semaglutide make you more fertile?

Yes, indirectly. Weight loss of 5-10% can restore ovulation in women with obesity-related anovulation, and semaglutide's average 15% weight loss often exceeds that threshold. Women with PCOS see particular benefit because semaglutide improves insulin resistance and can reduce androgen levels. Semaglutide also slows gastric emptying, which may reduce the absorption of oral contraceptives — the FDA updated the label to address this. If you're on semaglutide and don't want to become pregnant, confirm your birth control method is reliable with your provider.

Is semaglutide safe while breastfeeding?

Current guidance says no. Semaglutide has not been adequately studied in breastfeeding women. One small 2024 study of eight women found no detectable drug transfer into breast milk, which is biologically consistent with semaglutide being a large peptide molecule. But a single study with eight participants isn't enough to establish safety. Most providers advise against semaglutide during breastfeeding, especially in the first six months. After complementary foods are introduced, some may consider it on a case-by-case basis.

Does the oral Wegovy pill have different pregnancy risks than the injection?

Both contain semaglutide and carry the same pregnancy precautions. The oral pill (25 mg daily) has the same FDA labeling regarding pregnancy: discontinue at least two months before planned conception. The oral form may have an additional interaction with oral contraceptives beyond the gastric emptying effect — both the pill form and the hormonal contraceptive are absorbed through the GI tract. If you're on oral Wegovy and using oral birth control, discuss backup methods with your provider. The oral Wegovy guide covers other considerations about the pill formulation.

What are "Ozempic babies"?

"Ozempic babies" is a social media term for pregnancies that occur — often unexpectedly — in women taking semaglutide or other GLP-1 medications. The phenomenon is driven by weight loss restoring ovulation in women who were previously anovulatory, particularly those with PCOS or obesity-related infertility. The drug's effect on gastric emptying can also reduce oral contraceptive absorption, contributing to unplanned pregnancies. While the fertility improvement is real, GLP-1 medications are not approved or studied as fertility treatments.

Can my partner's semaglutide use affect our pregnancy?

Animal studies have not shown effects on male fertility from semaglutide. There is no evidence that a male partner's use of semaglutide affects sperm quality, conception, or fetal development. The drug is metabolized in the person taking it and does not transfer to a partner. If your male partner is on semaglutide and you're trying to conceive, his medication does not need to be stopped based on current evidence.